TSE:ACB - Aurora Cannabis Stock Price Target and Predictions

  • Consensus Rating: Sell
  • Consensus Price Target: C$9.43
  • Forecasted Upside: 9.78 %
  • Number of Analysts: 7
  • Breakdown:
  • 5 Sell Ratings
  • 2 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
C$8.59
▼ -0.43 (-4.77%)

This chart shows the closing price for ACB by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Aurora Cannabis Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ACB and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ACB

Analyst Price Target is C$9.43
▲ +9.78% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for Aurora Cannabis in the last 3 months. The average price target is C$9.43, with a high forecast of C$14.00 and a low forecast of C$6.00. The average price target represents a 9.78% upside from the last price of C$8.59.

This chart shows the closing price for ACB for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Sell

The current consensus among 7 polled investment analysts is to sell stock in Aurora Cannabis. This rating has held steady since January 2021, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 2 sell ratings
2/3/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 5 hold ratings
  • 2 sell ratings
5/3/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 5 hold ratings
  • 2 sell ratings
8/1/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 1 sell ratings
10/30/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 3 sell ratings
1/28/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 4 sell ratings
4/28/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 5 sell ratings
6/27/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 5 sell ratings
7/27/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 5 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
7/23/2021Atb Cap MarketsReiterated RatingUnderperform
5/17/2021Stifel NicolausLower Price TargetNAC$7.80 ➝ C$6.50
5/17/2021CIBCLower Price TargetUnderperformC$9.00 ➝ C$8.00
5/14/2021CowenLower Price TargetNAC$16.00 ➝ C$8.50
5/14/2021MKM PartnersLower Price TargetNAC$9.00 ➝ C$6.00
5/14/2021ATB CapitalDowngradeSector Perform ➝ UnderperformC$13.00
5/13/2021Atb Cap MarketsDowngradeSector Perform ➝ Underperform
5/11/2021CIBCLower Price TargetNeutral ➝ UnderperformC$15.00 ➝ C$9.00
5/11/2021Royal Bank of CanadaDowngradeUnderperform
2/24/2021Jefferies Financial GroupBoost Price TargetC$4.59 ➝ C$9.44
2/16/2021CIBCBoost Price TargetUnderperformC$18.50
2/12/2021Canaccord GenuityBoost Price TargetC$11.00 ➝ C$14.00
2/12/2021MKM PartnersReiterated RatingSell
2/12/2021Stifel NicolausBoost Price TargetC$6.50 ➝ C$7.80
2/12/2021ATB CapitalBoost Price TargetSector PerformC$10.50 ➝ C$13.00
2/8/2021CIBCBoost Price TargetC$15.00 ➝ C$17.00
11/17/2020ATB CapitalUpgradeUnderperform ➝ Sector Perform
11/16/2020Atb Cap MarketsUpgradeUnderperform ➝ Sector Perform
11/16/2020Jefferies Financial GroupLower Price TargetUnderperformC$6.90 ➝ C$4.93
11/10/2020CIBCBoost Price TargetC$12.00 ➝ C$15.00
11/10/2020CowenBoost Price TargetC$10.00 ➝ C$16.00
11/9/2020Atb Cap MarketsDowngradeSector Perform ➝ Underperform
11/9/2020Cantor FitzgeraldDowngradeOverweight ➝ Neutral
10/28/2020Stifel NicolausLower Price TargetC$10.50 ➝ C$3.60
9/29/2020Jefferies Financial GroupLower Price TargetC$8.70 ➝ C$6.90
9/24/2020CIBCLower Price TargetC$20.00 ➝ C$12.00
9/23/2020ATB CapitalLower Price TargetC$11.30 ➝ C$10.25
9/23/2020CowenLower Price TargetC$11.00 ➝ C$10.00
9/23/2020MKM PartnersLower Price TargetC$18.00 ➝ C$9.00
9/23/2020Pi FinancialLower Price TargetNeutralC$12.00 ➝ C$10.00
9/21/2020Canaccord GenuityLower Price TargetC$21.00 ➝ C$10.00
9/9/2020Stifel NicolausLower Price TargetC$16.00 ➝ C$10.50
9/9/2020ATB CapitalBoost Price TargetC$10.40 ➝ C$11.30
8/18/2020CIBCLower Price TargetC$24.00 ➝ C$20.00
6/24/2020Stifel NicolausUpgradeSell ➝ HoldC$6.20 ➝ C$17.50
6/24/2020Canaccord GenuityLower Price TargetC$24.00 ➝ C$21.00
5/28/2020AltaCorp CapitalBoost Price TargetC$2.50 ➝ C$10.40
5/25/2020CIBCBoost Price TargetC$14.00 ➝ C$24.00
5/22/2020Jefferies Financial GroupBoost Price TargetUnderperformC$12.00 ➝ C$14.00
5/19/2020Canaccord GenuityLower Price TargetC$27.00 ➝ C$24.00
5/19/2020CIBCLower Price TargetC$27.00 ➝ C$14.00
5/19/2020MKM PartnersBoost Price TargetC$12.00 ➝ C$18.00
5/18/2020CowenLower Price TargetC$12.00 ➝ C$11.00
5/12/2020CowenLower Price TargetC$12.00
5/12/2020Eight CapitalBoost Price TargetC$2.00 ➝ C$11.00
5/6/2020Pi FinancialSet Price TargetNeutralC$2.00
4/16/2020Jefferies Financial GroupLower Price TargetC$1.90 ➝ C$1.00
3/16/2020MKM PartnersLower Price TargetC$1.75 ➝ C$1.00
2/16/2020CIBCLower Price TargetC$2.50 ➝ C$2.25
2/16/2020Pi FinancialSet Price TargetNeutralC$2.00
2/14/2020Canaccord GenuityLower Price TargetC$3.00 ➝ C$2.25
2/10/2020Pi FinancialDowngradeBuy ➝ NeutralC$6.00 ➝ C$2.00
2/10/2020CIBCLower Price TargetC$5.00 ➝ C$2.50
2/7/2020Canaccord GenuityDowngradeSpeculative Buy ➝ HoldC$6.00 ➝ C$3.00
2/7/2020Eight CapitalDowngradeBuy ➝ NeutralC$6.00 ➝ C$2.00
2/7/2020Stifel NicolausLower Price TargetC$1.75 ➝ C$1.00
12/24/2019Jefferies Financial GroupDowngradeBuy ➝ HoldC$7.00 ➝ C$3.00
12/18/2019AltaCorp CapitalReiterated RatingSector Perform
12/17/2019LaurentianSet Price TargetBuyC$4.75
11/20/2019Pi FinancialLower Price TargetBuyC$7.00 ➝ C$6.00
11/15/2019Cantor FitzgeraldUpgradeNeutral ➝ Overweight
11/5/2019Cantor FitzgeraldReiterated RatingNeutral
10/11/2019Jefferies Financial GroupLower Price TargetC$14.00 ➝ C$7.00
9/24/2019CIBCReiterated RatingNeutralC$7.00
9/16/2019Stifel NicolausDowngradeHold ➝ SellC$7.00 ➝ C$5.00
9/13/2019DesjardinsLower Price TargetBuyC$16.50 ➝ C$14.00
5/3/2019Jefferies Financial GroupBoost Price TargetC$12.00 ➝ C$14.00
4/26/2019DesjardinsReiterated RatingBuyC$16.50
4/17/2019Bank of AmericaReiterated RatingBuyC$15.00
3/5/2019CowenReiterated RatingOutperformC$14.00
2/25/2019Jefferies Financial GroupReiterated RatingBuyC$12.00
2/21/2019Seaport Global SecuritiesReiterated RatingNeutral
1/9/2019Eight CapitalLower Price TargetC$17.00 ➝ C$15.00
9/26/2018Canaccord GenuityBoost Price TargetC$11.00 ➝ C$13.00
8/2/2018Eight CapitalReiterated RatingBuyC$9.00
4/18/2018Canaccord GenuityUpgradeHold ➝ Speculative BuyC$10.50 ➝ C$11.00
3/16/2018Canaccord GenuityDowngradeSpeculative Buy ➝ HoldC$4.45 ➝ C$11.00
11/13/2017Canaccord GenuityBoost Price TargetC$3.65 ➝ C$4.45
11/3/2017Canaccord GenuityBoost Price TargetC$3.25 ➝ C$3.65
9/27/2017Canaccord GenuityBoost Price TargetSpeculative BuyC$2.85 ➝ C$3.25
12/14/2016Canaccord GenuityBoost Price TargetC$2.75 ➝ C$3.15
11/2/2016Canaccord GenuitySet Price TargetSpeculative BuyC$2.75
(Data available from 7/28/2016 forward)
Aurora Cannabis logo
Aurora Cannabis Inc. produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories, including valves, screens, etc.; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and ROAR Sports. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
Read More

Today's Range

Now: C$8.59
Low: C$8.35
High: C$9.30

50 Day Range

MA: C$10.55
Low: C$8.59
High: C$12.38

52 Week Range

Now: C$8.59
Low: C$4.93
High: C$24.10

Volume

1,796,968 shs

Average Volume

3,225,490 shs

Market Capitalization

C$1.70 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Aurora Cannabis?

The following Wall Street analysts have issued research reports on Aurora Cannabis in the last year: Atb Cap Markets, ATB Capital, Canaccord Genuity, Cantor Fitzgerald, CIBC, Cowen Inc, Jefferies Financial Group Inc., MKM Partners, Pi Financial, Royal Bank of Canada, and Stifel Nicolaus.
View the latest analyst ratings for ACB.

What is the current price target for Aurora Cannabis?

8 Wall Street analysts have set twelve-month price targets for Aurora Cannabis in the last year. Their average twelve-month price target is C$9.43, suggesting a possible upside of 9.8%. Canaccord Genuity has the highest price target set, predicting ACB will reach C$14.00 in the next twelve months. MKM Partners has the lowest price target set, forecasting a price of C$6.00 for Aurora Cannabis in the next year.
View the latest price targets for ACB.

What is the current consensus analyst rating for Aurora Cannabis?

Aurora Cannabis currently has 5 sell ratings and 2 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Sell." A "sell" rating indicates that analysts believe ACB will underperform the market and that investors should sell shares of Aurora Cannabis.
View the latest ratings for ACB.

What other companies compete with Aurora Cannabis?

How do I contact Aurora Cannabis' investor relations team?

Aurora Cannabis' physical mailing address is 1500 - 1199 West Hastings St., VANCOUVER, BC V6E 3T5, Canada. The company's listed phone number is +1-604-3625207. The official website for Aurora Cannabis is auroramj.com.